PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Virbac SA ( ) from 1990 to Mar 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Virbac stock (VRBCF) PE ratio as of Mar 28 2024 is 23.96. More Details

Virbac SA (VRBCF) PE Ratio (TTM) Chart

To

Virbac SA (VRBCF) PE Ratio (TTM) Historical Data

Total 1194
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Virbac PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-03-28 23.4 2024-01-24 24.4
2024-03-27 23.4 2024-01-23 19.0
2024-03-26 23.4 2024-01-22 19.0
2024-03-25 23.4 2024-01-19 19.0
2024-03-22 23.4 2024-01-18 19.0
2024-03-21 23.7 2024-01-17 19.0
2024-03-20 23.7 2024-01-16 19.0
2024-03-19 23.7 2024-01-12 19.0
2024-03-18 23.7 2024-01-11 19.0
2024-03-15 25.4 2024-01-10 19.0
2024-03-14 25.4 2024-01-09 19.0
2024-03-13 25.4 2024-01-08 19.0
2024-03-12 25.4 2024-01-05 19.0
2024-03-11 22.8 2024-01-04 19.0
2024-03-08 22.8 2024-01-03 19.0
2024-03-07 22.8 2024-01-02 19.0
2024-03-06 22.8 2023-12-29 19.0
2024-03-05 22.8 2023-12-28 19.0
2024-03-04 24.4 2023-12-27 19.0
2024-03-01 24.4 2023-12-26 19.0
2024-02-29 24.4 2023-12-22 19.0
2024-02-28 24.4 2023-12-21 19.0
2024-02-27 24.4 2023-12-20 19.0
2024-02-26 24.4 2023-12-19 19.0
2024-02-23 24.4 2023-12-18 19.0
2024-02-22 24.4 2023-12-15 19.0
2024-02-21 24.4 2023-12-14 19.0
2024-02-20 24.4 2023-12-13 19.0
2024-02-16 24.4 2023-12-12 19.0
2024-02-15 24.4 2023-12-11 19.0
2024-02-14 24.4 2023-12-08 19.0
2024-02-13 24.4 2023-12-07 19.0
2024-02-12 24.4 2023-12-06 19.0
2024-02-09 24.4 2023-12-05 19.0
2024-02-08 24.4 2023-12-04 19.0
2024-02-07 24.4 2023-12-01 19.0
2024-02-06 24.4 2023-11-30 19.0
2024-02-05 24.4 2023-11-29 19.0
2024-02-02 24.4 2023-11-28 19.0
2024-02-01 24.4 2023-11-27 19.0
2024-01-31 24.4 2023-11-22 19.0
2024-01-30 24.4 2023-11-21 19.0
2024-01-29 24.4 2023-11-20 19.0
2024-01-26 24.4 2023-11-17 19.0
2024-01-25 24.4 2023-11-16 19.0

Virbac SA (VRBCF) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.